These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34246985)

  • 1. Utilizing feline oral squamous cell carcinoma patients to develop NQO1-targeted therapy.
    Lundberg AP; Boudreau MW; Selting KA; Chatkewitz LE; Samuelson J; Francis JM; Parkinson EI; Barger AM; Hergenrother PJ; Fan TM
    Neoplasia; 2021 Aug; 23(8):811-822. PubMed ID: 34246985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species.
    Lundberg AP; Francis JM; Pajak M; Parkinson EI; Wycislo KL; Rosol TJ; Brown ME; London CA; Dirikolu L; Hergenrother PJ; Fan TM
    Invest New Drugs; 2017 Apr; 35(2):134-144. PubMed ID: 27975234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxynyboquinones as NQO1-Activated Cancer Therapeutics.
    Parkinson EI; Hergenrother PJ
    Acc Chem Res; 2015 Oct; 48(10):2715-23. PubMed ID: 26444384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A virome sequencing approach to feline oral squamous cell carcinoma to evaluate viral causative factors.
    Chu S; Wylie TN; Wylie KM; Johnson GC; Skidmore ZL; Fleer M; Griffith OL; Bryan JN
    Vet Microbiol; 2020 Jan; 240():108491. PubMed ID: 31902496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C609T polymorphism of NAD(P)H quinone oxidoreductase 1 as a predictive biomarker for response to amrubicin.
    Takakuwa O; Oguri T; Ozasa H; Uemura T; Kunii E; Kasai D; Miyazaki M; Maeno K; Sato S
    J Thorac Oncol; 2011 Nov; 6(11):1826-32. PubMed ID: 21964527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-institutional epidemiologic study evaluating environmental risk factors for feline oral squamous cell carcinoma.
    Noall L; Lee S; Burton JH; Marquardt TM; Cermak J; Thombs LA; Rogic AM; Bryan JN; Chu S
    Vet Comp Oncol; 2023 Sep; 21(3):509-519. PubMed ID: 37243409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer.
    Zhang K; Chen D; Ma K; Wu X; Hao H; Jiang S
    J Med Chem; 2018 Aug; 61(16):6983-7003. PubMed ID: 29712428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting Attomolar DNA-Damaging Anticancer Drug Activity in Cell Lysates with Electrochemical DNA Devices.
    Wettasinghe AP; Singh N; Starcher CL; DiTusa CC; Ishak-Boushaki Z; Kahanda D; McMullen R; Motea EA; Slinker JD
    ACS Sens; 2021 Jul; 6(7):2622-2629. PubMed ID: 34156840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation.
    Xu S; Yao H; Pei L; Hu M; Li D; Qiu Y; Wang G; Wu L; Yao H; Zhu Z; Xu J
    Eur J Med Chem; 2017 May; 132():310-321. PubMed ID: 28395199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic significance of NADPH quinine oxidoreductase 1 overexpression in head and neck squamous cell carcinoma].
    Yang Y; Jin T; Liu S; Chen L; Lin L; Han H; Li L; Lin Z
    Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):463-7. PubMed ID: 25327796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
    Winski SL; Hargreaves RH; Butler J; Ross D
    Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Targeting of Protein Kinase CK2 Gene Expression in Feline Oral Squamous Cell Carcinoma: A Naturally Occurring Large-Animal Model of Head and Neck Cancer.
    Cannon CM; Trembley JH; Kren BT; Unger GM; O'Sullivan MG; Cornax I; Modiano JF; Ahmed K
    Hum Gene Ther Clin Dev; 2017 Jun; 28(2):80-86. PubMed ID: 28335614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining radiation therapy with zoledronate for the treatment of osteo-invasive feline oral squamous cell carcinoma.
    Lundberg AP; Tran Hoang C; Billhymer A; Selting KA
    Vet Comp Oncol; 2022 Dec; 20(4):788-796. PubMed ID: 35561080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Small Molecules as Stabilizers and Activators of Cancer-Associated NQO1 Polymorphisms.
    Pey AL; Megarity CF; Medina-Carmona E; Timson DJ
    Curr Drug Targets; 2016; 17(13):1506-14. PubMed ID: 26721407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite effects of arsenic trioxide on the Nrf2 pathway in oral squamous cell carcinoma in vitro and in vivo.
    Zhang X; Su Y; Zhang M; Sun Z
    Cancer Lett; 2012 May; 318(1):93-8. PubMed ID: 22155346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient NQO1 substrates are potent and selective anticancer agents.
    Parkinson EI; Bair JS; Cismesia M; Hergenrother PJ
    ACS Chem Biol; 2013 Oct; 8(10):2173-83. PubMed ID: 23937670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small molecule chaperone rescues the stability and activity of a cancer-associated variant of NAD(P)H:quinone oxidoreductase 1 in vitro.
    Strandback E; Lienhart WD; Hromic-Jahjefendic A; Bourgeois B; Högler A; Waltenstorfer D; Winkler A; Zangger K; Madl T; Gruber K; Macheroux P
    FEBS Lett; 2020 Feb; 594(3):424-438. PubMed ID: 31605637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective evaluation of toceranib phosphate (Palladia) in cats with oral squamous cell carcinoma.
    Wiles V; Hohenhaus A; Lamb K; Zaidi B; Camps-Palau M; Leibman N
    J Feline Med Surg; 2017 Feb; 19(2):185-193. PubMed ID: 26755491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A naturally occurring feline model of head and neck squamous cell carcinoma.
    Wypij JM
    Patholog Res Int; 2013; 2013():502197. PubMed ID: 23970998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.